These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32540764)

  • 41. Targeted Drug Delivery Based on Gold Nanoparticle Derivatives.
    Gholipourmalekabadi M; Mobaraki M; Ghaffari M; Zarebkohan A; Omrani VF; Urbanska AM; Seifalian A
    Curr Pharm Des; 2017; 23(20):2918-2929. PubMed ID: 28425863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid-Coated Gold Nanoparticles Functionalized by Folic Acid as Gene Vectors for Targeted Gene Delivery in vitro and in vivo.
    Du B; Gu X; Han X; Ding G; Wang Y; Li D; Wang E; Wang J
    ChemMedChem; 2017 Nov; 12(21):1768-1775. PubMed ID: 28967206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
    Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
    Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.
    de Oliveira R; Zhao P; Li N; de Santa Maria LC; Vergnaud J; Ruiz J; Astruc D; Barratt G
    Int J Pharm; 2013 Oct; 454(2):703-11. PubMed ID: 23701998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor.
    Shi Z; Chen X; Zhang L; Ding S; Wang X; Lei Q; Fang W
    Biomater Sci; 2018 Sep; 6(10):2582-2590. PubMed ID: 30151542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy.
    Chung HK; Choi SM; Ahn BO; Kwak HH; Kim JH; Kim WB
    Arzneimittelforschung; 2005; 55(10):573-80. PubMed ID: 16294503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
    Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
    Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Green Synthesis and Characterization of Monodispersed Gold Nanoparticles: Toxicity Study, Delivery of Doxorubicin and Its Bio-Distribution in Mouse Model.
    Mukherjee S; Sau S; Madhuri D; Bollu VS; Madhusudana K; Sreedhar B; Banerjee R; Patra CR
    J Biomed Nanotechnol; 2016 Jan; 12(1):165-81. PubMed ID: 27301182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of receptor recycling on the exocytosis of αvβ3 integrin targeted gold nanoparticles.
    Cui Y; Song X; Li S; He B; Yuan L; Dai W; Zhang H; Wang X; Yang B; Zhang Q
    Oncotarget; 2017 Jun; 8(24):38618-38630. PubMed ID: 28454098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Size dependent targeted delivery of gold nanoparticles modified with the IL-6R-specific aptamer AIR-3A to IL-6R-carrying cells.
    Prisner L; Bohn N; Hahn U; Mews A
    Nanoscale; 2017 Oct; 9(38):14486-14498. PubMed ID: 28929152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of functionalized silk-coated chitosan-gold nanoparticles and microparticles for target-directed delivery of antitumor agents.
    Horo H; Bhattacharyya S; Mandal B; Kundu LM
    Carbohydr Polym; 2021 Apr; 258():117659. PubMed ID: 33593545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Unprecedented Role of Gold Nanomaterial in Diabetes Management.
    Kumari S; Kamboj VK; Rajpoot D; Teotia AK; Verma PK; Singh GN
    Recent Pat Drug Deliv Formul; 2019; 13(3):219-227. PubMed ID: 30430950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release.
    Khutale GV; Casey A
    Eur J Pharm Biopharm; 2017 Oct; 119():372-380. PubMed ID: 28736333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Basic Properties of Gold Nanoparticles and their Applications in Tumor Diagnosis and Treatment.
    Bai X; Wang Y; Song Z; Feng Y; Chen Y; Zhang D; Feng L
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-Polymer Functionalised Gold Nanoparticles Show Efficient Mitochondrial Targeted Drug Delivery in Cervical Carcinoma Cells.
    Oladimeji O; Akinyelu J; Singh M
    J Biomed Nanotechnol; 2020 Jun; 16(6):853-866. PubMed ID: 33187581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
    Santonocito M; Zappulla C; Viola S; La Rosa LR; Solfato E; Abbate I; Tarallo V; Apicella I; Platania CBM; Maugeri G; D'Agata V; Bucolo C; De Falco S; Mazzone MG; Giuliano F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues.
    Amani A; Alizadeh MR; Yaghoubi H; Nohtani M
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111494. PubMed ID: 33255061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.